Werewolf Therapeutics, Inc. (HOWL) - Quarterly Income Statement

Home
HOWL
Financials

1.23 (USD) • At close March 12, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	1.143	0.742	1.501	5.897	8.081	4.464	7.283	4.97	4.148	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0.454	0.464	0.46	0.445	0.773	0.761	0.558	0.708	13.887	0.481	0.059	0.239	0.232	0.205	0	0	0	0
Gross Profit Numbers are in millions	0	0	0.689	0.278	1.041	5.452	7.308	3.703	6.725	4.262	-9.739	-0.481	-0.059	-0.239	-0.232	-0.205	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0.603	0.375	0.694	0.925	0.904	0.83	0.923	0.858	-2.348	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	15.727	12.528	15.271	12.908	9.649	10.838	9.583	11.706	15.859	13.07	13.887	10.945	13.4	9.787	7.265	4.817	5.286	4.812	3.78	2.763
General & Administrative Expenses Numbers are in millions	4.621	4.596	4.832	4.996	4.814	4.31	4.565	4.981	4.603	4.439	5.233	4.421	4.484	4.008	3.691	2.635	2.106	1.241	1.285	1.131
Selling & Marketing Expenses Numbers are in millions	0	0	-0.454	-0.464	-0.46	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	4.621	4.596	4.378	4.532	4.354	4.31	4.565	4.981	4.603	4.439	5.233	4.421	4.484	4.008	3.691	2.635	2.106	1.241	1.285	1.131
Other Expenses Numbers are in millions	0	0	1.613	-0.001	-0.006	0.966	-0.025	0.241	1.249	0.003	0.281	0	0.015	0	-0.016	-0.016	-0.038	0	7.298	0
Operating Expenses Numbers are in millions	20.348	17.124	19.649	17.44	14.003	15.148	14.148	16.687	20.462	17.509	19.12	15.366	17.884	13.795	10.956	7.452	7.392	6.053	5.065	3.894
Operating Income Numbers are in millions	-20.348	-17.124	-18.96	-17.162	-12.962	-9.251	-6.067	-12.223	-13.179	-12.539	-14.972	-15.366	-17.884	-13.795	-10.956	-7.452	-7.392	-6.053	-5.065	-3.894
Operating Income Ratio Numbers are in millions	0	0	-16.588	-23.129	-8.636	-1.569	-0.751	-2.738	-1.81	-2.523	-3.609	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	-0.052	0.451	1.711	0.969	0.959	0.966	0.969	0.241	1.249	0.596	0.378	0.023	0.015	0.037	0.035	0.017	-0.01	-0.015	7.322	0.067
Income Before Tax Numbers are in millions	-20.4	-16.673	-17.249	-16.193	-12.003	-8.285	-5.098	-11.982	-11.93	-11.943	-14.594	-15.343	-17.869	-13.758	-10.921	-7.435	-7.402	-6.068	2.257	-3.827
Income Before Tax Ratio Numbers are in millions	0	0	-15.091	-21.823	-7.997	-1.405	-0.631	-2.684	-1.638	-2.403	-3.518	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	-0	2.105	-0.445	-0.994	-0.666	-1.249	-0.596	-0.378	-0.023	-0.048	-0.172	-0.051	-0.033	-0.028	0	-0.024	0
Net Income Numbers are in millions	-20.4	-16.673	-17.249	-16.193	-12.003	-8.285	-5.098	-11.316	-10.681	-11.347	-14.216	-15.32	-17.869	-13.758	-10.921	-7.435	-7.402	-6.068	2.257	-3.827
Net Income Ratio Numbers are in millions	0	0	-15.091	-21.823	-7.997	-1.405	-0.631	-2.535	-1.467	-2.283	-3.427	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	0	-0.38	-0.4	-0.39	-0.33	-0.23	-0.14	-0.33	-0.35	-0.38	-0.52	-0.56	-0.66	-0.51	-0.62	-0.28	-0.83	-0.68	0.25	-0.43
EPS Diluted Numbers are in millions	0	-0.38	-0.4	-0.39	-0.33	-0.23	-0.14	-0.33	-0.35	-0.38	-0.52	-0.56	-0.66	-0.51	-0.62	-0.28	-0.83	-0.68	0.25	-0.43
EBITDA Numbers are in millions	-18.691	-16.67	-15.653	-14.726	-10.304	-8.806	-4.325	-11.221	-12.762	-12.135	-14.787	-15.268	-17.81	-13.728	-10.894	-7.413	-7.348	-6.012	-5.023	-3.871
EBITDA Ratio Numbers are in millions	0	0	-16.191	-22.504	-8.329	-1.569	-0.697	-2.738	-1.81	-2.442	-3.565	0	0	0	0	0	0	0	0	0

Werewolf Therapeutics, Inc.

NASDAQ:HOWL Add to watchlist

NASDAQ:HOWL